Category
All
New Technology
Service & Software
Internet & Communication
Electronics & Semiconductor
Pharma & Healthcare
Other
Energy & Power
Agriculture
Consumer Goods
Machinery & Equipment
Food & Beverages
Medical Care
Automobile & Transportation
Packaging
Chemical & Material
Medical Devices & Consumables
Category
All
Total: 2 records, 1 pages
Search For: Poly-L-lactic Acid (PLLA) Sirolimus-eluting Coronary Stent System
Global Poly-L-lactic Acid (PLLA) Sirolimus-eluting Coronary Stent System Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
06 Sep 2024
Medical Devices & Consumables
Poly-L-lactic Acid (PLLA) Sirolimus-eluting Coronary Stent System
A poly-L-lactic acid (PLLA) sirolimus-eluting coronary stent system is a medical device used to treat narrowed or blocked coronary arteries. The system comprises a bioabsorbable stent made from poly-L-lactic acid (PLLA) and coated with the drug sirolimus. After implantation, the stent provides mechanical support to keep the vessel open, while the sirolimus coating is gradually released to inhibit endothelial cell proliferation and reduce the risk of restenosis. Over time, the PLLA stent is absorbed and metabolized by the body, eventually disappearing, which allows the vessel to return to its natural state and reduces complications associated with long-term implantation.
USD3480.00
Add To Cart
Global Poly-L-lactic Acid (PLLA) Sirolimus-eluting Coronary Stent System Supply, Demand and Key Producers, 2024-2030
06 Sep 2024
Medical Devices & Consumables
Poly-L-lactic Acid (PLLA) Sirolimus-eluting Coronary Stent System
A poly-L-lactic acid (PLLA) sirolimus-eluting coronary stent system is a medical device used to treat narrowed or blocked coronary arteries. The system comprises a bioabsorbable stent made from poly-L-lactic acid (PLLA) and coated with the drug sirolimus. After implantation, the stent provides mechanical support to keep the vessel open, while the sirolimus coating is gradually released to inhibit endothelial cell proliferation and reduce the risk of restenosis. Over time, the PLLA stent is absorbed and metabolized by the body, eventually disappearing, which allows the vessel to return to its natural state and reduces complications associated with long-term implantation.
USD4480.00
Add To Cart
Popular Product Keywords
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
Search For: Poly-L-lactic Acid (PLLA) Sirolimus-eluting Coronary Stent System
Total: 2 records, 1 pages
06 Sep 2024
Medical Devices & Consumables
Poly-L-lactic Acid (PLLA) Sirolimus-eluting Coronary Stent System
A poly-L-lactic acid (PLLA) sirolimus-eluting coronary stent system is a medical device used to treat narrowed or blocked coronary arteries. The system comprises a bioabsorbable stent made from poly-L-lactic acid (PLLA) and coated with the drug sirolimus. After implantation, the stent provides mechanical support to keep the vessel open, while the sirolimus coating is gradually released to inhibit endothelial cell proliferation and reduce the risk of restenosis. Over time, the PLLA stent is absorbed and metabolized by the body, eventually disappearing, which allows the vessel to return to its natural state and reduces complications associated with long-term implantation.
USD3480.00
Add To Cart
06 Sep 2024
Medical Devices & Consumables
Poly-L-lactic Acid (PLLA) Sirolimus-eluting Coronary Stent System
A poly-L-lactic acid (PLLA) sirolimus-eluting coronary stent system is a medical device used to treat narrowed or blocked coronary arteries. The system comprises a bioabsorbable stent made from poly-L-lactic acid (PLLA) and coated with the drug sirolimus. After implantation, the stent provides mechanical support to keep the vessel open, while the sirolimus coating is gradually released to inhibit endothelial cell proliferation and reduce the risk of restenosis. Over time, the PLLA stent is absorbed and metabolized by the body, eventually disappearing, which allows the vessel to return to its natural state and reduces complications associated with long-term implantation.
USD4480.00
Add To Cart
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
-
- Digging deeper into global industry information and providing market strategies.Contact Us >>